Viking Global Opportunities Parent GP LLC's Net Worth
$1.48 Billion
Who is Viking Global Opportunities Parent GP LLC?
Viking Global Opportunities Parent GP LLC has an estimated net worth of $1.48 Billion. This is based on reported shares across multiple companies, which include Amylyx Pharmaceuticals, Inc., RayzeBio, Inc., 4D Molecular Therapeutics, Inc., Roivant Sciences Ltd., BridgeBio Pharma, Inc., Ginkgo Bioworks Holdings, Inc., Rallybio Corp, Frazier Lifesciences Acquisition Corp, Inhibrx, Inc., and PROCEPT BioRobotics Corp.
SEC CIK
Viking Global Opportunities Parent GP LLC's CIK is 0001886738
Past Insider Trading and Trends
2023 was Viking Global Opportunities Parent GP LLC's most active year for acquiring shares with 15 total transactions. Viking Global Opportunities Parent GP LLC's most active month to acquire stocks was the month of August. 2022 was Viking Global Opportunities Parent GP LLC's most active year for disposing of shares, totalling 22 transactions. Viking Global Opportunities Parent GP LLC's most active month to dispose stocks was the month of August. 2022 saw Viking Global Opportunities Parent GP LLC paying a total of $72,238,379.62 for 299,350,986 shares, this is the most they've acquired in one year. In 2023 Viking Global Opportunities Parent GP LLC cashed out on 24,882,756 shares for a total of $181,200,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Amylyx Pharmaceuticals, Inc. (AMLX) Snapshot price: $15.275
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -10.26% | -1.40M |
$29.80 | -$41,719,639.31 | 12.24M |
Sep 8 - Sep 9
| |||
Form 4
|
∞
| 7.17M |
$19.00 | $43,700,000.00 | 7.17M |
Jan 11 - Nov 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RayzeBio, Inc. (RYZB) Snapshot price: $62.13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.64M |
—
|
—
|
0
|
Feb 26
| |||
Form 4
| -100.00% | -6.64M |
—
|
—
|
0
|
Feb 26
| |||
Form 4
|
∞
| 6.64M |
$18.00 |
—
| 6.64M |
Sep 19
| |||
Form 4
|
∞
| 6.64M |
$18.00 |
—
| 6.64M |
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
4D Molecular Therapeutics, Inc. (FDMT) Snapshot price: $28.4887
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -11.28% | -540.00K |
$19.53 | -$10,546,200.00 | 4.25M |
Jan 4
| |||
Form 4
| +21.59% | 850K |
$16.00 | $13,600,000.00 | 4.79M |
May 9
| |||
| No matching records found | |||||||||
Roivant Sciences Ltd. (ROIV) Snapshot price: $10.395
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -14.73% | -13.00M |
$9.90 | -$128,700,000.00 | 75.24M |
Jun 22
| |||
| No matching records found | |||||||||
BridgeBio Pharma, Inc. (BBIO) Snapshot price: $33.62
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.63% | -1.50M |
$35.00 | -$52,500,000.00 | 25.12M |
Jul 18
| |||
| No matching records found | |||||||||